Erratum to: Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy (Molecular Neurobiology, 10.1007/s12035-015-9423-8);Tonic GABA A Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy

Molecular Neurobiology

Volumn 53, Issue 8, 2016, Pages 5252-5265

  Schipper, S ^a,b   Aalbers, M W ^b   Rijkers, K ^b,c   Swijsen, A ^d   Rigo, J M ^d   Hoogland, G ^a,b   Vles, J S H ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Atrium Hospital   (Netherlands)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

Antiepileptic drugs; Epilepsy; Extrasynaptic GABA A receptor; Seizures; Tonic

Indexed keywords

4 AMINO 5 HEXYNOIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ALFAXALONE; ANTICONVULSIVE AGENT; CYCLOSERINE; ETHANOLAMINE SULFATE; GABA TRANSPORTER 1; GABA TRANSPORTER 2; GABA TRANSPORTER 3; GABACULINE; GABOXADOL; GANAXOLONE; NEUROSTEROID; PHENYLETHYLIDENEHYDRAZINE; PROPOFOL; SNAP 5114; TIAGABINE; UNCLASSIFIED DRUG; VIGABATRIN;

ANTICONVULSANT ACTIVITY; CLINICAL TRIAL (TOPIC); CLUSTER ANALYSIS; CONCENTRATION (PARAMETERS); DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG TARGETING; EXTRACELLULAR SPACE; FOCAL EPILEPSY; HUMAN; INTERNEURON; NERVE CELL INHIBITION; NEUROPATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; TEMPORAL LOBE EPILEPSY; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; ANTICONVULSANTS; EPILEPSY, TEMPORAL LOBE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; RECEPTORS, GABA-A; SIGNAL TRANSDUCTION;

EID: 84944710319     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9479-5     Document Type: Erratum

References (137)

1. World Health Organization (2012) Epilepsy Fact Sheet http://www.who.int/mediacentre/factsheets/fs999/en/. Accessed 30th november 2014
2. Wiebe S (2000) Epidemiology of temporal lobe epilepsy. Can J Neurol Sci Le J Can Sci Neurol 27(1):S6–10
3. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342(5):314–319. doi:10.1056/NEJM200002033420503
4. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51(6):1069–1077. doi:10.1111/j.1528-1167.2009.02397.x
5. Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6(3):215–229. doi:10.1038/nrn1625
6. Glykys J, Mody I (2007) Activation of GABAA receptors: views from outside the synaptic cleft. Neuron 56(5):763–770. doi:10.1016/j.neuron.2007.11.002
7. Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ et al (2004) Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 101(10):3662–3667. doi:10.1073/pnas.0307231101
8. Semyanov A, Walker MC, Kullmann DM, Silver RA (2004) Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 27(5):262–269. doi:10.1016/j.tins.2004.03.005
9. Pavlov I, Savtchenko LP, Kullmann DM, Semyanov A, Walker MC (2009) Outwardly rectifying tonically active GABAA receptors in pyramidal cells modulate neuronal offset, not gain. J Neurosci Off J Soc Neurosci 29(48):15341–15350. doi:10.1523/JNEUROSCI.2747-09.2009
10. Holter NI, Zylla MM, Zuber N, Bruehl C, Draguhn A (2010) Tonic GABAergic control of mouse dentate granule cells during postnatal development. Eur J Neurosci 32(8):1300–1309. doi:10.1111/j.1460-9568.2010.07331.x
11. Mann EO, Mody I (2010) Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons. Nat Neurosci 13(2):205–212. doi:10.1038/nn.2464
12. Martin LJ, Zurek AA, MacDonald JF, Roder JC, Jackson MF, Orser BA (2010) Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory. J Neurosci Off J Soc Neurosci 30(15):5269–5282. doi:10.1523/JNEUROSCI.4209-09.2010
13. Duveau V, Laustela S, Barth L, Gianolini F, Vogt KE, Keist R, Chandra D, Homanics GE et al (2011) Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. Eur J Neurosci 34(3):362–373. doi:10.1111/j.1460-9568.2011.07782.x
14. Ge S, Goh EL, Sailor KA, Kitabatake Y, Ming GL, Song H (2006) GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 439(7076):589–593. doi:10.1038/nature04404
15. Mody I, Pearce RA (2004) Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 27(9):569–575. doi:10.1016/j.tins.2004.07.002
16. Luscher B, Keller CA (2004) Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacol Ther 102(3):195–221. doi:10.1016/j.pharmthera.2004.04.003
17. Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60(3):243–260. doi:10.1124/pr.108.00505
18. Rudolph U, Mohler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475–498. doi:10.1146/annurev.pharmtox.44.101802.121429
19. Lee V, Maguire J (2014) The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circ 8:3. doi:10.3389/fncir.2014.00003
20. Sieghart W, Sperk G (2002) Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2(8):795–816
21. Wei W, Zhang N, Peng Z, Houser CR, Mody I (2003) Perisynaptic localization of delta subunit-containing GABA(A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci: Off J Soc Neurosci 23(33):10650–10661
22. Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci: Off J Soc Neurosci 18(5):1693–1703
23. Glykys J, Mody I (2006) Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. J Neurophysiol 95(5):2796–2807. doi:10.1152/jn.01122.2005
24. Semyanov A, Walker MC, Kullmann DM (2003) GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6(5):484–490. doi:10.1038/nn1043
25. Stell BM, Brickley SG, Tang CY, Farrant M, Mody I (2003) Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100(24):14439–14444. doi:10.1073/pnas.2435457100
26. Glykys J, Mann EO, Mody I (2008) Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus? J Neurosci: Off J Soc Neurosci 28(6):1421–1426. doi:10.1523/JNEUROSCI.4751-07.2008
27. Serwanski DR, Miralles CP, Christie SB, Mehta AK, Li X, De Blas AL (2006) Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain. J Comp Neurol 499(3):458–470. doi:10.1002/cne.21115
28. Michels G, Moss SJ (2007) GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42(1):3–14. doi:10.1080/10409230601146219
29. Knoflach F, Benke D, Wang Y, Scheurer L, Luddens H, Hamilton BJ, Carter DB, Mohler H et al (1996) Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2. Mol Pharmacol 50(5):1253–1261
30. Fisher JL, Macdonald RL (1997) Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells. J Physiol 505(Pt 2):283–297
31. Bohme I, Rabe H, Luddens H (2004) Four amino acids in the alpha subunits determine the gamma-aminobutyric acid sensitivities of GABAA receptor subtypes. J Biol Chem 279(34):35193–35200. doi:10.1074/jbc.M405653200
32. Minier F, Sigel E (2004) Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 101(20):7769–7774. doi:10.1073/pnas.0400220101
33. Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA (2002) Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br J Pharmacol 136(7):965–974. doi:10.1038/sj.bjp.0704795
34. Rossi DJ, Hamann M (1998) Spillover-mediated transmission at inhibitory synapses promoted by high affinity alpha6 subunit GABA(A) receptors and glomerular geometry. Neuron 20(4):783–795
35. Otis TS, Staley KJ, Mody I (1991) Perpetual inhibitory activity in mammalian brain slices generated by spontaneous GABA release. Brain Res 545(1–2):142–150
36. Barbour B, Hausser M (1997) Intersynaptic diffusion of neurotransmitter. Trends Neurosci 20(9):377–384
37. Wall MJ, Usowicz MM (1997) Development of action potential-dependent and independent spontaneous GABAA receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur J Neurosci 9(3):533–548
38. Rossi DJ, Hamann M, Attwell D (2003) Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J Physiol 548(Pt 1):97–110. doi:10.1113/jphysiol.2002.036459
39. Yoon BE, Lee CJ (2014) GABA as a rising gliotransmitter. Frontiers Neural Circ 8:141. doi:10.3389/fncir.2014.00141
40. Zilberter Y, Kaiser KM, Sakmann B (1999) Dendritic GABA release depresses excitatory transmission between layer 2/3 pyramidal and bitufted neurons in rat neocortex. Neuron 24(4):979–988
41. Le Meur K, Mendizabal-Zubiaga J, Grandes P, Audinat E (2012) GABA release by hippocampal astrocytes. Front Comput Neurosci 6:59. doi:10.3389/fncom.2012.00059
42. Kozlov AS, Angulo MC, Audinat E, Charpak S (2006) Target cell-specific modulation of neuronal activity by astrocytes. Proc Natl Acad Sci U S A 103(26):10058–10063. doi:10.1073/pnas.0603741103
43. Jimenez-Gonzalez C, Pirttimaki T, Cope DW, Parri HR (2011) Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets delta-subunit-containing GABA(A) receptors. Eur J Neurosci 33(8):1471–1482. doi:10.1111/j.1460-9568.2011.07645.x
44. Lee S, Yoon BE, Berglund K, Oh SJ, Park H, Shin HS, Augustine GJ, Lee CJ (2010) Channel-mediated tonic GABA release from glia. Science 330(6005):790–796. doi:10.1126/science.1184334
45. Attwell D, Barbour B, Szatkowski M (1993) Nonvesicular release of neurotransmitter. Neuron 11(3):401–407
46. Cammack JN, Rakhilin SV, Schwartz EA (1994) A GABA transporter operates asymmetrically and with variable stoichiometry. Neuron 13(4):949–960
47. Levi G, Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci 16(10):415–419
48. Lu CC, Hilgemann DW (1999) GAT1 (GABA:Na+:Cl-) cotransport function. Kinetic studies in giant Xenopus oocyte membrane patches. J Gen Physiol 114(3):445–457
49. O’Malley DM, Sandell JH, Masland RH (1992) Co-release of acetylcholine and GABA by the starburst amacrine cells. J Neurosci: Off J Soc Neurosci 12(4):1394–1408
50. Pin JP, Bockaert J (1989) Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J Neurosci: Off J Soc Neurosci 9(2):648–656
51. Schwartz EA (1987) Depolarization without calcium can release gamma-aminobutyric acid from a retinal neuron. Science 238(4825):350–355
52. Wlodarczyk AI, Sylantyev S, Herd MB, Kersante F, Lambert JJ, Rusakov DA, Linthorst AC, Semyanov A et al (2013) GABA-independent GABAA receptor openings maintain tonic currents. J Neurosci: Off J Soc Neurosci 33(9):3905–3914. doi:10.1523/JNEUROSCI.4193-12.2013
53. McCartney MR, Deeb TZ, Henderson TN, Hales TG (2007) Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating. Mol Pharmacol 71(2):539–548. doi:10.1124/mol.106.028597
54. Sigel E, Baur R, Malherbe P, Mohler H (1989) The rat beta 1-subunit of the GABAA receptor forms a picrotoxin-sensitive anion channel open in the absence of GABA. FEBS Lett 257(2):377–379
55. Maksay G, Thompson SA, Wafford KA (2003) The pharmacology of spontaneously open alpha 1 beta 3 epsilon GABA A receptor-ionophores. Neuropharmacology 44(8):994–1002
56. Lindquist CE, Dalziel JE, Cromer BA, Birnir B (2004) Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously. Eur J Pharmacol 496(1–3):23–32. doi:10.1016/j.ejphar.2004.06.004
57. Birnir B, Everitt AB, Lim MS, Gage PW (2000) Spontaneously opening GABA(A) channels in CA1 pyramidal neurones of rat hippocampus. J Membrane Biol 174(1):21–29
58. Maguire J, Mody I (2008) GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 59(2):207–213. doi:10.1016/j.neuron.2008.06.019
59. Maguire J, Mody I (2009) Steroid hormone fluctuations and GABA(A)R plasticity. Psychoneuroendocrinology 34(Suppl 1):S84–90. doi:10.1016/j.psyneuen.2009.06.019
60. Tao W, Higgs MH, Spain WJ, Ransom CB (2013) Postsynaptic GABAB receptors enhance extrasynaptic GABAA receptor function in dentate gyrus granule cells. J Neurosci Off J Soc Neurosci 33(9):3738–3743. doi:10.1523/JNEUROSCI.4829-12.2013
61. Connelly WM, Fyson SJ, Errington AC, McCafferty CP, Cope DW, Di Giovanni G, Crunelli V (2013) GABAB receptors regulate extrasynaptic GABAA receptors. J Neurosci Off J Soc Neurosci 33(9):3780–3785. doi:10.1523/JNEUROSCI.4989-12.2013
62. Scanziani M, Gahwiler BH, Thompson SM (1991) Paroxysmal inhibitory potentials mediated by GABAB receptors in partially disinhibited rat hippocampal slice cultures. J Physiol 444:375–396
63. During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341(8861):1607–1610
64. Barbaresi P (2007) Cellular and subcellular localization of the GABA(B) receptor 1a/b subunit in the rat periaqueductal gray matter. J Comp Neurol 505(5):478–492. doi:10.1002/cne.21509
65. Andersson M, Blomstrand F, Hanse E (2007) Astrocytes play a critical role in transient heterosynaptic depression in the rat hippocampal CA1 region. J Physiol 585(Pt 3):843–852. doi:10.1113/jphysiol.2007.142737
66. Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ (2012) Gephyrin, the enigmatic organizer at GABAergic synapses. Front Cell Neurosci 6:23. doi:10.3389/fncel.2012.00023
67. Jacob TC, Moss SJ, Jurd R (2008) GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 9(5):331–343. doi:10.1038/nrn2370
68. Loebrich S, Bahring R, Katsuno T, Tsukita S, Kneussel M (2006) Activated radixin is essential for GABAA receptor alpha5 subunit anchoring at the actin cytoskeleton. EMBO J 25(5):987–999. doi:10.1038/sj.emboj.7600995
69. Thomas P, Mortensen M, Hosie AM, Smart TG (2005) Dynamic mobility of functional GABAA receptors at inhibitory synapses. Nat Neurosci 8(7):889–897. doi:10.1038/nn1483
70. Bogdanov Y, Michels G, Armstrong-Gold C, Haydon PG, Lindstrom J, Pangalos M, Moss SJ (2006) Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts. EMBO J 25(18):4381–4389. doi:10.1038/sj.emboj.7601309
71. Petrini EM, Marchionni I, Zacchi P, Sieghart W, Cherubini E (2004) Clustering of extrasynaptic GABA(A) receptors modulates tonic inhibition in cultured hippocampal neurons. J Biol Chem 279(44):45833–45843. doi:10.1074/jbc.M407229200
72. Chen L, Wang H, Vicini S, Olsen RW (2000) The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics. Proc Natl Acad Sci U S A 97(21):11557–11562. doi:10.1073/pnas.190133497
73. Semyanov A (2003) Cell type specificity of GABA(A) receptor mediated signaling in the hippocampus. Curr Drug Targets CNS Neurol Disord 2(4):240–247
74. Brickley SG, Cull-Candy SG, Farrant M (1996) Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol 497(Pt 3):753–759
75. Song I, Savtchenko L, Semyanov A (2011) Tonic excitation or inhibition is set by GABA(A) conductance in hippocampal interneurons. Nat Commun 2:376. doi:10.1038/ncomms1377
76. Cope DW, Di Giovanni G, Fyson SJ, Orban G, Errington AC, Lorincz ML, Gould TM, Carter DA et al (2009) Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med 15(12):1392–1398. doi:10.1038/nm.2058
77. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST (2010) Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468(7321):305–309. doi:10.1038/nature09511
78. Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S et al (2004) GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13(13):1315–1319. doi:10.1093/hmg/ddh146
79. Feng HJ, Kang JQ, Song L, Dibbens L, Mulley J, Macdonald RL (2006) Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors. J Neurosci: Off J Soc Neurosci 26(5):1499–1506. doi:10.1523/JNEUROSCI.2913-05.2006
80. Eugene E, Depienne C, Baulac S, Baulac M, Fritschy JM, Le Guern E, Miles R, Poncer JC (2007) GABA(A) receptor gamma 2 subunit mutations linked to human epileptic syndromes differentially affect phasic and tonic inhibition. J Neurosci: Off J Soc Neurosci 27(51):14108–14116. doi:10.1523/JNEUROSCI.2618-07.2007
81. Feng Y, Kapornai K, Kiss E, Tamas Z, Mayer L, Baji I, Daroczi G, Benak I et al (2010) Association of the GABRD gene and childhood-onset mood disorders. Genes Brain Behav 9(6):668–672. doi:10.1111/j.1601-183X.2010.00598.x
82. Schwarzer C, Sperk G (1995) Hippocampal granule cells express glutamic acid decarboxylase-67 after limbic seizures in the rat. Neuroscience 69(3):705–709
83. Fritschy JM, Kiener T, Bouilleret V, Loup F (1999) GABAergic neurons and GABA(A)-receptors in temporal lobe epilepsy. Neurochem Int 34(5):435–445
84. Bouilleret V, Loup F, Kiener T, Marescaux C, Fritschy JM (2000) Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus 10(3):305–324. doi:10.1002/1098-1063(2000)10:3<305::AID-HIPO11>3.0.CO;2-I
85. Drexel M, Kirchmair E, Sperk G (2013) Changes in the expression of GABAA receptor subunit mRNAs in parahippocampal areas after kainic acid induced seizures. Front Neural Circ 7:142. doi:10.3389/fncir.2013.00142
86. Nishimura T, Schwarzer C, Gasser E, Kato N, Vezzani A, Sperk G (2005) Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience 134(2):691–704. doi:10.1016/j.neuroscience.2005.04.013
87. Tsunashima K, Schwarzer C, Kirchmair E, Sieghart W, Sperk G (1997) GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy. Neuroscience 80(4):1019–1032
88. Scimemi A, Semyanov A, Sperk G, Kullmann DM, Walker MC (2005) Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci: Off J Soc Neurosci 25(43):10016–10024. doi:10.1523/JNEUROSCI.2520-05.2005
89. Zhang N, Wei W, Mody I, Houser CR (2007) Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci: Off J Soc Neurosci 27(28):7520–7531. doi:10.1523/JNEUROSCI.1555-07.2007
90. Peng Z, Huang CS, Stell BM, Mody I, Houser CR (2004) Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci: Off J Soc Neurosci 24(39):8629–8639. doi:10.1523/JNEUROSCI.2877-04.2004
91. Rajasekaran K, Joshi S, Sun C, Mtchedlishvilli Z, Kapur J (2010) Receptors with low affinity for neurosteroids and GABA contribute to tonic inhibition of granule cells in epileptic animals. Neurobiol Dis 40(2):490–501. doi:10.1016/j.nbd.2010.07.016
92. Scimemi A, Andersson A, Heeroma JH, Strandberg J, Rydenhag B, McEvoy AW, Thom M, Asztely F et al (2006) Tonic GABA(A) receptor-mediated currents in human brain. Eur J Neurosci 24(4):1157–1160. doi:10.1111/j.1460-9568.2006.04989.x
93. Goodkin HP, Joshi S, Mtchedlishvili Z, Brar J, Kapur J (2008) Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J Neurosci Off J Soc Neurosci 28(10):2527–2538. doi:10.1523/JNEUROSCI.3426-07.2008
94. Naylor DE, Liu H, Wasterlain CG (2005) Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci Off J Soc Neurosci 25(34):7724–7733. doi:10.1523/JNEUROSCI.4944-04.2005
95. Sperk G, Schwarzer C, Heilman J, Furtinger S, Reimer RJ, Edwards RH, Nelson N (2003) Expression of plasma membrane GABA transporters but not of the vesicular GABA transporter in dentate granule cells after kainic acid seizures. Hippocampus 13(7):806–815. doi:10.1002/hipo.10133
96. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP et al (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52(3):453–472
97. Andre V, Marescaux C, Nehlig A, Fritschy JM (2001) Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11(4):452–468. doi:10.1002/hipo.1060
98. Esclapez M, Houser CR (1999) Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J Comp Neurol 412(3):488–505
99. Freichel C, Potschka H, Ebert U, Brandt C, Loscher W (2006) Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience 141(4):2177–2194. doi:10.1016/j.neuroscience.2006.05.040
100. Ding R, Asada H, Obata K (1998) Changes in extracellular glutamate and GABA levels in the hippocampal CA3 and CA1 areas and the induction of glutamic acid decarboxylase-67 in dentate granule cells of rats treated with kainic acid. Brain Res 800(1):105–113
101. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 94(25):14060–14065
102. Pavlov I, Walker MC (2013) Tonic GABA(A) receptor-mediated signalling in temporal lobe epilepsy. Neuropharmacology 69:55–61. doi:10.1016/j.neuropharm.2012.04.003
103. Schwarzer C, Tsunashima K, Wanzenbock C, Fuchs K, Sieghart W, Sperk G (1997) GABA(A) receptor subunits in the rat hippocampus II: altered distribution in kainic acid-induced temporal lobe epilepsy. Neuroscience 80(4):1001–1017
104. Zhan RZ, Nadler JV (2009) Enhanced tonic GABA current in normotopic and hilar ectopic dentate granule cells after pilocarpine-induced status epilepticus. J Neurophysiol 102(2):670–681. doi:10.1152/jn.00147.2009
105. Lee B, Lee H, Nam YR, Oh JH, Cho YH, Chang JW (2005) Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther 12(15):1215–1222. doi:10.1038/sj.gt.3302520
106. Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, Moirano J, Fitzsimons H et al (2007) Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 27(3):501–509. doi:10.1038/sj.jcbfm.9600364
107. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D et al (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial. Lancet 369(9579):2097–2105. doi:10.1016/S0140-6736(07)60982-9
108. LeWitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM, Group USS (2008) Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson’s disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 63(3):295–302. doi:10.1002/ana.21315
109. Grove J, Fozard JR, Mamont PS (1981) Assay of alpha-difluoromethylornithine in body fluids and tissues by automatic amino-acid analysis. J Chromatogr 223(2):409–416
110. Mumford JP, Dam M (1989) Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 27(Suppl 1):101S–107S
111. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ (1977) gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 29(5):797–802
112. Angehagen M, Ben-Menachem E, Ronnback L, Hansson E (2003) Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res 28(2):333–340
113. Leach JP, Sills GJ, Majid A, Butler E, Carswell A, Thompson GG, Brodie MJ (1996) Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes. Seizure 5(3):229–234
114. Duffy S, Nguyen PV, Baker GB (2004) Phenylethylidenehydrazine, a novel GABA-transaminase inhibitor, reduces epileptiform activity in rat hippocampal slices. Neuroscience 126(2):423–432. doi:10.1016/j.neuroscience.2004.03.007
115. Loscher W (1980) A comparative study of the pharmacology of inhibitors of GABA-metabolism. Naunyn Schmiedeberg’s Arch Pharmacol 315(2):119–128
116. Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269(2):219–224
117. Fink-Jensen A, Suzdak PD, Swedberg MD, Judge ME, Hansen L, Nielsen PG (1992) The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220(2–3):197–201
118. Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S et al (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 9(15):1–157, iii-iv
119. Kellinghaus C, Loddenkemper T, Weitemeyer L, Ludemann P (2001) Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile. Nervenarzt 72(10):764–769
120. Bialer M, White HS (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9(1):68–82. doi:10.1038/nrd2997
121. Reddy DS, Rogawski MA (2012) Neurosteroids—endogenous regulators of seizure susceptibility and role in the treatment of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper’s Basic Mechanisms of the Epilepsies. 4th edn., Bethesda (MD)
122. Reddy DS, Rogawski MA (2010) Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res 89(2–3):254–260. doi:10.1016/j.eplepsyres.2010.01.009
123. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2013) Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res 103(1):2–30. doi:10.1016/j.eplepsyres.2012.10.001
124. Kerrigan JF, Shields WD, Nelson TY, Bluestone DL, Dodson WE, Bourgeois BF, Pellock JM, Morton LD et al (2000) Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res 42(2–3):133–139
125. Wan L, Liu X, Wu Z, Ren W, Kong S, Dargham RA, Cheng L, Wang Y (2014) Activation of extrasynaptic GABAA receptors inhibits cyclothiazide-induced epileptiform activity in hippocampal CA1 neurons. Neurosci Bull 30(5):866–876. doi:10.1007/s12264-014-1466-8
126. Sun Y, Wu Z, Kong S, Jiang D, Pitre A, Wang Y, Chen G (2013) Regulation of epileptiform activity by two distinct subtypes of extrasynaptic GABAA receptors. Mole Brain 6:21. doi:10.1186/1756-6606-6-21
127. Petersen HR, Jensen I, Dam M (1983) THIP: a single-blind controlled trial in patients with epilepsy. Acta Neurol Scand 67(2):114–117
128. Hansen SL, Sperling BB, Sanchez C (2004) Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuro-Psychopharmacol Biol Psychiatry 28(1):105–113. doi:10.1016/j.pnpbp.2003.09.026
129. Loscher W, Schwark WS (1985) Evaluation of different GABA receptor agonists in the kindled amygdala seizure model in rats. Exp Neurol 89(2):454–460
130. Wafford KA, van Niel MB, Ma QP, Horridge E, Herd MB, Peden DR, Belelli D, Lambert JJ (2009) Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus. Neuropharmacology 56(1):182–189. doi:10.1016/j.neuropharm.2008.08.004
131. Crunelli V, Leresche N, Cope DW (2012) GABA-A receptor function in typical absence seizures. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper’s Basic Mechanisms of the Epilepsies. 4th edn., Bethesda (MD)
132. Prenosil GA, Schneider Gasser EM, Rudolph U, Keist R, Fritschy JM, Vogt KE (2006) Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol 96(2):846–857. doi:10.1152/jn.01199.2006
133. Krook-Magnuson E, Soltesz I (2015) Beyond the hammer and the scalpel: selective circuit control for the epilepsies. Nat Neurosci 18(3):331–338. doi:10.1038/nn.3943
134. Aston-Jones G, Deisseroth K (2013) Recent advances in optogenetics and pharmacogenetics. Brain Res 1511:1–5. doi:10.1016/j.brainres.2013.01.026
135. Katzel D, Nicholson E, Schorge S, Walker MC, Kullmann DM (2014) Chemical-genetic attenuation of focal neocortical seizures. Nat Commun 5:3847. doi:10.1038/ncomms4847
136. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW et al (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298(5594):846–850. doi:10.1126/science.1072873
137. Cook DJ, Teves L, Tymianski M (2012) Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483(7388):213–217. doi:10.1038/nature10841